KMC Speciality Hospitals Intrinsic Value

KMC Speciality Hospitals intrinsic value. KMC Speciality Hospitals (KMCSHIL) median intrinsic value is ₹131.25 from 9 valuation models (range ₹51–₹423), vs current price ₹169.38 — -22.5% downside (Trading Above Calculated Value), margin of safety -29.1%. Read KMCSHIL dividend yield for the complete payout history and dividend yield track record.

Market Price (CMP)
₹169.38
Primary Intrinsic Value
₹50.81
Market Cap
₹271.0 Cr
-22.5% Downside
Median Value
₹131.25
Value Range
₹51 - ₹423
Assessment
Trading Above Calculated Value
Safety Margin
-29.1%

KMCSHIL Valuation Methods Summary — DCF, Graham Number & P/E

KMC Speciality Hospitals intrinsic value across 9 models vs current price ₹169.38 — upside/downside and value range per method. Compare with KMCSHIL fair price to assess whether the stock is under or overvalued.

Method Type Intrinsic Value Range Upside/Downside Details
P/E Based Valuation earnings ₹50.81 ₹40.65 - ₹60.97 -70.0% EPS: ₹3.40, Sector P/E: 12x
Book Value Method asset ₹131.25 ₹118.12 - ₹144.38 -22.5% Book Value/Share: ₹131.25, P/B: 1.0x
Revenue Multiple Method revenue ₹168.50 ₹151.65 - ₹185.35 -0.5% Revenue/Share: ₹210.62, P/S: 0.8x
EBITDA Multiple Method earnings ₹338.76 ₹304.88 - ₹372.64 +100.0% EBITDA: ₹106.00Cr, EV/EBITDA: 6x
Simple DCF (5Y) dcf ₹423.45 ₹338.76 - ₹508.14 +150.0% CF Growth: 15.0%, Discount: 15%
PEG Ratio Method growth ₹54.38 ₹48.94 - ₹59.82 -67.9% EPS Growth: 20.0%, Fair P/E: 16.0x
Growth Adjusted P/E growth ₹50.81 ₹45.73 - ₹55.89 -70.0% Revenue Growth: 15.0%, Adj P/E: 8.6x
ROE Based Valuation profitability ₹338.76 ₹304.88 - ₹372.64 +100.0% ROE: 26.7%, P/E Multiple: 16x
Graham Defensive Method conservative ₹100.20 ₹90.18 - ₹110.22 -40.8% EPS: ₹3.40, BVPS: ₹131.25
Method Types: Earnings Asset DCF Growth Dividend Conservative

KMCSHIL Intrinsic Value vs Market Price — All Valuation Models

KMC Speciality Hospitals fair value range ₹51–₹423 vs current market price ₹169.38 across 9 valuation models. For current market price and key ratios, visit KMCSHIL share price screener.

KMCSHIL Intrinsic Value Analysis — Undervalued or Overvalued?

KMC Speciality Hospitals median intrinsic value ₹131.25, current price ₹169.38 — Trading Above Calculated Value by 22.5%, margin of safety -29.1%.

What is the intrinsic value of KMCSHIL?

Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of KMC Speciality Hospitals (KMCSHIL) is ₹131.25 (median value). With the current market price of ₹169.38, this represents a -22.5% variance from our estimated fair value.

The valuation range spans from ₹50.81 to ₹423.45, indicating ₹50.81 - ₹423.45.

Is KMCSHIL undervalued or overvalued?

Based on our multi-method analysis, KMC Speciality Hospitals (KMCSHIL) appears to be trading above calculated value by approximately 22.5%.

KMCSHIL Financial Health — Key Ratios vs Industry Benchmarks

KMC Speciality Hospitals financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.

Financial Metric Current Value Industry Benchmark Assessment Impact on Valuation
Current Ratio 1.03 Industry Standard: 2.0+ Below 1.5 Measures short-term liquidity capacity
Return on Equity 26.7% Industry Standard: 15%+ Above 15% Measures shareholder return efficiency
Operating Margin 30.0% Industry Standard: 20%+ Above 20% Indicates operational efficiency level
Asset Turnover Ratio 1.02x Industry Standard: 1.0x+ Above 1.0x Measures asset utilization efficiency

KMCSHIL Cash Flow Quality — Operating & Free Cash Flow

KMC Speciality Hospitals operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.

Period Operating Cash Flow Free Cash Flow Cash Flow Quality Sustainability Score
March 2026 ₹79 Cr ₹71 Cr Positive Free Cash Flow 8/10
March 2025 ₹58 Cr ₹33 Cr Positive Free Cash Flow 8/10
March 2024 ₹38 Cr ₹10 Cr Positive Free Cash Flow 7/10
March 2023 ₹32 Cr ₹8 Cr Positive Free Cash Flow 7/10
March 2022 ₹29 Cr ₹15 Cr Positive Free Cash Flow 7/10